Market Overview
Global Bone Cement Syringe market size was valued at USD 287.6 million in 2024. The market is projected to grow from USD 302.9 million in 2025 to USD 436.8 million by 2032, exhibiting a CAGR of 5.3% during the forecast period.
Bone cement syringes are specialized medical devices designed for precise delivery of polymethylmethacrylate (PMMA) bone cement during orthopedic and trauma surgeries.
These devices play a critical role in procedures like vertebroplasty, kyphoplasty, and joint replacement surgeries by ensuring controlled cement application while minimizing leakage risks. The market offers both disposable and reusable variants, with disposable syringes gaining traction due to infection control advantages.
USD 287.6 million in 2024
2032
USD 436.8 million by 2032,
of 5.3%
Disposable Bone Cement Syringes Segment Dominates Due to Rising Demand for Sterile and SingleUse Medical Devices
The market is segmented based on type into:
Disposable Bone Cement Syringes
Subtypes: Pre-filled syringes, manual mixing syringes
Reusable Bone Cement Syringes
Subtypes: Stainless steel syringes, autoclavable polymer syringes
By Application
Orthopedic
Fractures and Joint Replacement Procedures
1.The market is segmented based on application into:
Orthopedic Surgery
Subtypes:
Dental Surgery
Neurosurgery
Others
https://www.24lifesciences.com
Our Key Players
Stryker Corporation (U.S.)
Zimmer Biomet Holdings, Inc. (U.S.)
DePuy Synthes (Johnson & Johnson) (U.S.)
Teknimed (France)
Synimed Synergie Ingénierie Médicale (France)
Seawon Meditech (South Korea)
ASA DENTAL S.p.A. (Italy)
BPB MEDICA - Biopsybell S.r.l. (Italy)
